Truong Vu 4
4 · Aridis Pharmaceuticals, Inc. · Filed Apr 6, 2020
Insider Transaction Report
Form 4
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Exercise/Conversion
Stock Options
2020-04-03+50,000→ 546,050 totalExercise: $5.24Exp: 2030-04-03→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The Stock Options vest in equal installments over 12 months, beginning on April 3, 2020.